Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

SELL
$122.0 - $145.31 $610 - $726
-5 Reduced 45.45%
6 $0
Q2 2023

Jul 11, 2023

SELL
$122.5 - $147.16 $367 - $441
-3 Reduced 21.43%
11 $1,000
Q1 2022

May 05, 2022

SELL
$129.64 - $160.7 $907 - $1,124
-7 Reduced 33.33%
14 $2,000
Q4 2021

Feb 02, 2022

SELL
$119.87 - $145.67 $9,949 - $12,090
-83 Reduced 79.81%
21 $3,000
Q3 2021

Oct 19, 2021

BUY
$128.64 - $184.79 $1,415 - $2,032
11 Added 11.83%
104 $14,000
Q2 2021

Jul 28, 2021

SELL
$160.2 - $186.42 $480 - $559
-3 Reduced 3.13%
93 $17,000
Q1 2021

Apr 28, 2021

BUY
$150.19 - $173.5 $5,406 - $6,246
36 Added 60.0%
96 $16,000
Q4 2020

Jan 26, 2021

BUY
$140.71 - $165.05 $6,894 - $8,087
49 Added 445.45%
60 $10,000
Q3 2020

Oct 19, 2020

BUY
$105.46 - $144.13 $1,160 - $1,585
11 New
11 $2,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.